The impact of osteocalcin, osteoprotegerin and osteopontin on arterial stiffness in chronic renal failure patients on hemodialysis
B Csiky, B Sági, A Peti, O Lakatos, V Prémusz… - Kidney and Blood …, 2018 - karger.com
Abstract Background/Aims: This cross-sectional study was designed to assess the
relationship between vascular stiffness (VS) and bone-related proteins involved in the …
relationship between vascular stiffness (VS) and bone-related proteins involved in the …
[HTML][HTML] Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients …
Background Cardiovascular morbidity and mortality are highly prevalent in patients with end-
stage renal disease, and osteoprotegerin (OPG) may be an important link between bone …
stage renal disease, and osteoprotegerin (OPG) may be an important link between bone …
[HTML][HTML] Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease
Patients with chronic kidney disease (CKD) have an extremely poor cardiovascular
outcome. Arterial stiffness, a strong independent predictor of survival in CKD, is connected to …
outcome. Arterial stiffness, a strong independent predictor of survival in CKD, is connected to …
[HTML][HTML] Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients
A Nakashima, JJ Carrero, AR Qureshi, T Hirai… - Osteoporosis …, 2011 - Springer
A high circulating osteoprotegerin (OPG) level may be a risk factor for vascular calcification
and mortality in hemodialysis patients. OPG and pulse wave velocity (PWV) were measured …
and mortality in hemodialysis patients. OPG and pulse wave velocity (PWV) were measured …
[HTML][HTML] The correlation of serum osteoprotegerin with non-traditional cardiovascular risk factors and arterial stiffness in patients with pre-dialysis chronic kidney …
SY Chae, WK Chung, YH Kim, YK Oh… - Journal of Korean …, 2018 - ncbi.nlm.nih.gov
Background Osteoprotegerin (OPG) plays protective roles against the development of
vascular calcification (VC) which greatly contributes to the increased cardiovascular events …
vascular calcification (VC) which greatly contributes to the increased cardiovascular events …
Osteocalcin association with vascular function in chronic kidney disease
X Guo, Y Li, Y Zhou, C Zhang, S Liang… - The Journal of …, 2022 - Wiley Online Library
Osteocalcin (OCN) is a bone‐derived and vitamin K dependent hormone that affects energy
metabolism and vascular calcification. The relationship between serum OCN and vascular …
metabolism and vascular calcification. The relationship between serum OCN and vascular …
Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease
ND Toussaint, KK Lau, BJ Strauss… - Nephrology Dialysis …, 2008 - academic.oup.com
Background. Vascular calcification (VC) and arterial stiffness are major contributors to
cardiovascular (CV) disease in chronic kidney disease (CKD). Both are independent …
cardiovascular (CV) disease in chronic kidney disease (CKD). Both are independent …
The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis
K Nitta, T Akiba, K Uchida, A Kawashima… - American journal of …, 2003 - Elsevier
BACKGROUND:: The aortic calcification index (ACI), estimated on abdominal computed
tomographic scans, has been associated with the extent of arteriosclerosis in hemodialysis …
tomographic scans, has been associated with the extent of arteriosclerosis in hemodialysis …
Calcaneal osteopenia is a new marker for arterial stiffness in chronic hemodialysis patients
N Joki, H Hase, M Shiratake, N Kishi… - American journal of …, 2005 - karger.com
Background: A high frequency of simultaneous low estimated bone mineral density (BMD)
and atherosclerotic vascular disease is found in chronic dialysis patients. The degree of …
and atherosclerotic vascular disease is found in chronic dialysis patients. The degree of …
[HTML][HTML] Serum OPG and RANKL levels as risk factors for the development of cardiovascular calcifications in end-stage renal disease patients in hemodialysis
M Spartalis, E Kasimatis, E Liakou, E Sampani… - Life, 2023 - mdpi.com
Cardiovascular calcifications (CVC) are frequently observed in chronic kidney disease
(CKD) patients and contribute to their cardiovascular mortality. The aim of the present study …
(CKD) patients and contribute to their cardiovascular mortality. The aim of the present study …